Cidara Therapeutics Shares Outstanding 2014-2021 | CDTX

Cidara Therapeutics shares outstanding from 2014 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Cidara Therapeutics Annual Shares Outstanding
(Millions of Shares)
2020 42
2019 30
2018 26
2017 18
2016 14
2015 10
2014 1
2013 0
Cidara Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2021-09-30 50
2021-06-30 59
2021-03-31 47
2020-12-31 42
2020-09-30 43
2020-06-30 41
2020-03-31 38
2019-12-31 30
2019-09-30 40
2019-06-30 29
2019-03-31 29
2018-12-31 26
2018-09-30 28
2018-06-30 24
2018-03-31 21
2017-12-31 18
2017-09-30 17
2017-06-30 17
2017-03-31 17
2016-12-31 14
2016-09-30 14
2016-06-30 14
2016-03-31 14
2015-12-31 10
2015-09-30 14
2015-06-30 11
2015-03-31 1
2014-12-31 1
2014-09-30 1
2014-06-30 1
2014-03-31 0
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.059B $0.012B
Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives. Its product pipeline includes CD101 IV, a long-acting echinocandin antifungal, CD101 topical and C001 which are in different clinical trial. The company developed its product using Cloudbreak(TM) immunotherapy platform. Cidara Therapeutics, Inc. is headquartered in San Diego, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.033B 9.10
Bio-Rad Laboratories (BIO.B) United States $17.971B 36.47
QIAGEN (QGEN) Netherlands $11.044B 18.70
Biohaven Pharmaceutical Holding (BHVN) United States $7.729B 0.00
Emergent Biosolutions (EBS) United States $2.541B 9.14
Arcus Biosciences (RCUS) United States $2.414B 0.00
Myovant Sciences (MYOV) United Kingdom $1.374B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.167B 0.00
Zymeworks (ZYME) Canada $0.623B 0.00
Ambrx Biopharma (AMAM) United States $0.231B 0.00
SQZ Biotechnologies (SQZ) United States $0.214B 0.00
Enzo Biochem (ENZ) United States $0.161B 20.75